• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

阿尔茨海默病的新诊断标准：哪些标准、何时采用以及为何如此？

New criteria for Alzheimer's disease: which, when and why?

作者信息

Schott Jonathan M, Petersen Ronald C

机构信息

1 Dementia Research Centre, UCL Institute of Neurology, London, UK

2 Alzheimer's Disease Research Centre, Mayo Clinic, Rochester, USA.

出版信息

Brain. 2015 May;138(Pt 5):1134-7. doi: 10.1093/brain/awv055.

DOI:10.1093/brain/awv055
PMID:25907755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5963410/
Abstract

This scientific commentary refers to ‘Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage’ by Vos (doi:10.1093/brain/awv029).

摘要

本科学评论参考了沃斯所著的《轻度认知障碍阶段阿尔茨海默病的患病率和预后》（doi:10.1093/brain/awv029）。

相似文献

1
New criteria for Alzheimer's disease: which, when and why?阿尔茨海默病的新诊断标准：哪些标准、何时采用以及为何如此？
Brain. 2015 May;138(Pt 5):1134-7. doi: 10.1093/brain/awv055.
2
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.轻度认知障碍阶段阿尔茨海默病的患病率及预后
Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. Epub 2015 Feb 17.
3
Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.轻度认知障碍或阿尔茨海默病患者的突发性精神病
J Clin Psychiatry. 2016 Dec;77(12):e1564-e1569. doi: 10.4088/JCP.15m10617.
4
[Alzheimer's disease--treatment with and without drugs].[阿尔茨海默病——药物治疗与非药物治疗]
MMW Fortschr Med. 2012 Apr 19;154(7):85-7, 89-90.
5
Frequency of Depressive Syndromes in Elderly Individuals with No Cognitive Impairment, Mild Cognitive Impairment, and Alzheimer's Disease Dementia in a Memory Clinic Setting.记忆门诊中无认知障碍、轻度认知障碍和阿尔茨海默病痴呆的老年人抑郁综合征的发生率
Dement Geriatr Cogn Disord. 2016;42(3-4):135-145. doi: 10.1159/000449155. Epub 2016 Sep 20.
6
Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama.巴拿马老年人阿尔茨海默病和轻度认知障碍的特征
J Alzheimers Dis. 2016 Oct 4;54(3):897-901. doi: 10.3233/JAD-160402.
7
[Organization of out-patient psychiatric care in dementia and cognitive impairment. Part I: Memory clinics and Alzheimer's disease centers].[痴呆与认知障碍的门诊精神科护理组织。第一部分：记忆诊所与阿尔茨海默病中心]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):111-119. doi: 10.17116/jnevro201711761111-119.
8
Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study.基于南里奥格兰德州老年人队列的阿尔茨海默病轻度认知障碍向阿尔茨海默病转化风险的评估：PALA 研究。
Int Psychogeriatr. 2012 Apr;24(4):674-81. doi: 10.1017/S1041610211002043. Epub 2011 Nov 17.
9
Incidence of and risk factors for Alzheimer's disease and mild cognitive impairment in Korean elderly.韩国老年人阿尔茨海默病及轻度认知障碍的发病率和危险因素
Dement Geriatr Cogn Disord. 2015;39(1-2):105-15. doi: 10.1159/000366555. Epub 2014 Nov 11.
10
Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment.轻度认知障碍的多成分认知干预的长期观察。
J Clin Psychiatry. 2012 Dec;73(12):e1492-8. doi: 10.4088/JCP.11m07270.

引用本文的文献

1
Sirt-1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress.Sirt-1 调节生理过程并发挥抗氧化应激的保护作用。
Biomed Res Int. 2021 Mar 23;2021:5542545. doi: 10.1155/2021/5542545. eCollection 2021.
2
Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine.健脑益智方联合常规西药治疗阿尔茨海默病的临床体会。
Chin J Integr Med. 2020 Mar;26(3):212-218. doi: 10.1007/s11655-019-2718-2. Epub 2020 Mar 16.
3
Challenges of Integrative Disease Modeling in Alzheimer's Disease.阿尔茨海默病综合疾病建模的挑战
Front Mol Biosci. 2020 Jan 14;6:158. doi: 10.3389/fmolb.2019.00158. eCollection 2019.
4
A short perspective on the long road to effective treatments for Alzheimer's disease.关于阿尔茨海默病有效治疗漫长之路的简短展望。
Br J Pharmacol. 2019 Sep;176(18):3636-3648. doi: 10.1111/bph.14581. Epub 2019 Mar 1.
5
Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer's disease diagnosis and prognosis.用于阿尔茨海默病诊断和预后的纳米级物理生物标志物和认知评估的计算整合。
Sci Adv. 2017 Jul 28;3(7):e1700669. doi: 10.1126/sciadv.1700669. eCollection 2017 Jul.
6
Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.阿尔茨海默病和语义性痴呆中网络破坏与萎缩的不同进展
J Alzheimers Dis. 2017;55(3):981-993. doi: 10.3233/JAD-160571.

本文引用的文献

1
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.轻度认知障碍阶段阿尔茨海默病的患病率及预后
Brain. 2015 May;138(Pt 5):1327-38. doi: 10.1093/brain/awv029. Epub 2015 Feb 17.
2
Tau imaging: early progress and future directions.tau 成像：早期进展与未来方向。
Lancet Neurol. 2015 Jan;14(1):114-24. doi: 10.1016/S1474-4422(14)70252-2.
3
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.推进阿尔茨海默病研究诊断标准：IWG-2 标准。
Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0.
4
Mild cognitive impairment due to Alzheimer disease in the community.阿尔茨海默病导致的社区获得性轻度认知障碍。
Ann Neurol. 2013 Aug;74(2):199-208. doi: 10.1002/ana.23931.
5
Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges.确定阿尔茨海默病生物标志物的截断值：统计问题、方法和挑战。
Biomark Med. 2012 Aug;6(4):391-400. doi: 10.2217/bmm.12.49.
6
Clinical amyloid imaging in Alzheimer's disease.阿尔茨海默病的临床淀粉样蛋白成像。
Lancet Neurol. 2011 Jul;10(7):667-70. doi: 10.1016/S1474-4422(11)70123-5.
7
Clinical practice. Mild cognitive impairment.临床实践。轻度认知障碍。
N Engl J Med. 2011 Jun 9;364(23):2227-34. doi: 10.1056/NEJMcp0910237.
8
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.阿尔茨海默病所致轻度认知障碍的诊断：美国国家老龄化研究所-阿尔茨海默病协会诊断指南工作组的建议。
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
9
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.阿尔茨海默病的脑脊液和血浆生物标志物。
Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16.
10
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.阿尔茨海默病诊断的研究标准：修订NINCDS-ADRDA标准
Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3.